Title |
Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma
|
---|---|
Published in |
PLOS ONE, August 2013
|
DOI | 10.1371/journal.pone.0071816 |
Pubmed ID | |
Authors |
Min-Li Mo, Junichi Okamoto, Zhao Chen, Tomomi Hirata, Iwao Mikami, Geneviève Bosco-Clément, Hui Li, Hai-Meng Zhou, David M. Jablons, Biao He |
Abstract |
Lung cancer is a common cancer and the leading cause of cancer-related death worldwide. SIX3 is a human homologue of the highly conserved sine oculis gene family essential during embryonic development in vertebrates, and encodes a homeo-domain containing transcription factor. Little is known about the role of SIX3 in human tumorigenesis. This study is to assess the expression/function of SIX3 and the significance of SIX3 as a prognostic biomarker in lung adenocarcinoma. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 7% |
Unknown | 14 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 33% |
Student > Bachelor | 2 | 13% |
Student > Ph. D. Student | 2 | 13% |
Student > Doctoral Student | 1 | 7% |
Professor > Associate Professor | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 4 | 27% |
Medicine and Dentistry | 3 | 20% |
Biochemistry, Genetics and Molecular Biology | 2 | 13% |
Social Sciences | 1 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Other | 0 | 0% |
Unknown | 4 | 27% |